CELGENE CORPORATION for CELGENE CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Corporate Tax Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
Copyright/Patent/Trademark CPT
HR 9, "Innovation Act", provisions regarding patent reform. S 632, "STRONG Patents Act", provisions regarding patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Health Issues HCR
HR 2841, "FAST Generic Act of 2015", regarding risk evaluation and mitigation strategy. HR 2739/S 1566, "Cancer Drug Coverage Parity Act", regarding all provisions. HR 1600, "Patients Access To Treatments Act", regarding all provisions. HR 6, "21st Century Cures", regarding all provisions. Issues related to Medicare Part D/Part B. Issues related to the Afforable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.